Drug maker tests Easier-to-Swallow version of approved medicine
NCT ID NCT07297199
Summary
This study aims to see if a new liquid tablet form of the drug omaveloxolone (SKYCLARYS®) is processed by the body the same way as the currently available capsules. It involves about 70 healthy adults who will take both forms of the drug in a specific order, with a break in between. The main goal is to check if the two forms are equivalent, while also monitoring for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Trialmed formerly PPD, Austin Clinical Research Unit
RECRUITINGAustin, Texas, 78744, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.